1,2 Initially developed as antidiabetic treatments, GLP-1 RAs and, more recently, dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have demonstrated favourable metabolic outcomes with significant and sustainable weight loss in large randomised controlled trials (RCTs) and real-world studies
[22] Peptides with pharmacological activity intended for human use including growth hormone secretagogues are likely to be classified as POMs by default if they were licensed, and their unlicensed supply for human use is therefore unlawful
When the body is stuck in a fight-or-flight state, healing becomes nearly impossible
Do not copy another persons HCG protocol
Although levothyroxine may treat hypothyroidism and reduce hypothyroid headaches, headache can be a potential side effect of levothyroxine , so its not a surefire treatment for hypothyroid headache